Aktis Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aktis Oncology and other ETFs, options, and stocks.About AKTS
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
CEOMatthew Roden
CEOMatthew Roden
Employees79
Employees79
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2020
Founded2020
Employees79
Employees79
AKTS Key Statistics
Market cap1.09B
Market cap1.09B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume239.33K
Average volume239.33K
High today—
High today—
Low today—
Low today—
Open price$20.93
Open price$20.93
Volume0.00
Volume0.00
52 Week high$29.16
52 Week high$29.16
52 Week low$0.0372
52 Week low$0.0372
Stock Snapshot
With a market cap of 1.09B, Aktis Oncology(AKTS) trades at $20.50.
On 2026-04-22, Aktis Oncology(AKTS) shares started trading at $20.93, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 239.33K.
The stock's 52-week range extends from a low of $0.04 to a high of $29.16.
The stock's 52-week range extends from a low of $0.04 to a high of $29.16.
People also own
Based on the portfolios of people who own AKTS. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.